36 studies found for:    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Show Display Options
Rank Status Study
21 Recruiting Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)
Condition: Chronic Inflammatory Demyelinating Neuropathy
Intervention: Drug: Alemtuzumab infusion
22 Completed Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Intervention: Drug: Subcutaneous immunoglobulin
23 Completed Study of CIDP Patients During IVIG Treatment
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Intervention: Drug: intravenous gammaglobulin
24 Recruiting Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Biological: HYQVIA;   Biological: 0.25% albumin placebo solution with rHuPH20;   Biological: IGIV
25 Enrolling by invitation MRI in Diagnosing and Monitoring CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Intervention:
26 Recruiting Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Intervention: Drug: I10E
27 Not yet recruiting Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Intervention: Drug: I10E
28 Not yet recruiting Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
Condition: Chronic Inflammatory Demyelinating Polyneuropathy
Intervention: Drug: H.P. Acthar® Gel
29 Terminated Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Drug: NewGam 10%;   Drug: Placebo
30 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Intervention: Drug: Immune globulin
31 Not yet recruiting Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy
Condition: Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy
Intervention: Drug: NewGam
32 Recruiting IVIg for Demyelination in Diabetes Mellitus
Conditions: Peripheral Neuropathy;   Diabetes Mellitus;   Chronic Inflammatory Demyelinating Polyneuropathy
Interventions: Drug: 10% intravenous immunoglobulin (IVIg);   Drug: 0.9% sodium chloride
33 Completed Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Intervention: Drug: immune globulin
34 Recruiting Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy;   Hereditary Axonal Neuropathy;   Hereditary Demyelinated Neuropathy;   Polyneuropathy, Inflammatory Demyelinating, Chronic
Intervention:
35 Recruiting Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Condition: Stiff Person Syndrome
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplantation
36 Recruiting Interest of Mycophenolate for CIDP Weaning
Condition: Chronic Inflammatory Demyelinating Polyradiculopathy
Interventions: Drug: Mycophenolate Mofetil;   Drug: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years